hMSCs as an alternative therapeutic option for asthma with neutrophil mediated inflammation
Crossref DOI link: https://doi.org/10.1038/s12276-018-0072-7
Published Online: 2018-06-07
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cruz, Fernanda F.
Rocco, Patricia R. M.
Weiss, Daniel J.
Text and Data Mining valid from 2018-06-01
Article History
Received: 14 February 2017
Accepted: 5 February 2018
First Online: 7 June 2018
Conflict of interest
: The authors declare no competing interests.